Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos, C Teunissen… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION We assessed whether co‐morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. METHODS In 1090 non …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos, C Teunissen… - Alzheimer's & …, 2023 - discovery.ucl.ac.uk
INTRODUCTION: We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease.//METHODS: In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease.//METHODS: In 1090 non …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos… - … & dementia: the …, 2024 - pubmed.ncbi.nlm.nih.gov
Introduction We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. Methods In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. Methods In 1090 non …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos… - Alzheimer's & …, 2024 - cris.maastrichtuniversity.nl
INTRODUCTION: We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos… - Alzheimer's …, 2023 - researchinformation.amsterdamumc …
INTRODUCTION: We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
[HTML][HTML] Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos, C Teunissen… - Alzheimer's & …, 2024 - ncbi.nlm.nih.gov
METHODS In 1090 non‐demented participants (65.4±10.7 years) SVD was assessed with
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
JEF Moonen, R Haan, I Bos, C Teunissen… - … & Dementia: the …, 2023 - europepmc.org
Methods In 1090 non-demented participants (65.4±10.7 years) SVD was assessed with
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos, C Teunissen… - Alzheimer's and …, 2024 - research.vu.nl
INTRODUCTION: We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
JEF Moonen, R Haan, I Bos, C Teunissen… - … & Dementia: the …, 2023 - europepmc.org
Methods In 1090 non-demented participants (65.4±10.7 years) SVD was assessed with
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
magnetic resonance imaging and amyloid beta (Aβ) with lumbar puncture and/or positron …
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
JEF Moonen, R Haan, I Bos… - Alzheimer's …, 2024 - researchinformation.amsterdamumc …
INTRODUCTION: We assessed whether co-morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …
predictive value in preclinical or prodromal Alzheimer's disease. METHODS: In 1090 non …